IMAGE SOURCE: GETTY IMAGES.
There’s good news and bad news in 2016 for Inovio Pharmaceuticals (NASDAQ: INO) shareholders. The good news is that Inovio’s stock is up around 30% year to date. What’s the bad news? Shares were up close to 70% in June before giving up some of those gains.